secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALISADE BIO, INC. (PALI)
CIK:        0001357459
Form:       8-K
Filed at:   2025-09-05T23:59:59+00:00
Accession:  0001493152-25-012687
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Palisade Bio adopts Phantom Unit Plan, grants 10M cash-settled units, amends exec employment agreements
--------------------------------------------------------------------------------

- Phantom Unit Plan approved; up to 10,000,000 cash-settled phantom units may be granted.
- CEO J.D. Finley granted 323,400 Phantom Units; CMO Mitchell Jones 289,000; SVP Ryker Willie 137,600.
- Board Chair granted 64,400 units; each other independent director granted 37,600 units.
- Executives' phantom units vest quarterly over 3 years; directors vest annually over 3 years.
- Amended employment agreements: CEO base $575K, CMO $440K, SVP Finance $298.5K, with enhanced severance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357459/000149315225012687/0001493152-25-012687-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357459/000149315225012687/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-012687

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer